Table 3.
End point | Variable | Exp (B) | Lower 95% CL of Exp (B) | Upper 95% CL Exp (B) | p-value |
---|---|---|---|---|---|
Pain relief | α/β =2 Gy | 1.072 | 1.002 | 1.146 | 0.043* |
Pain relief | α/β =10 Gy | 1.087 | 1.012 | 1.168 | 0.023* |
Pain relief | target volume | 1.088 | 1.015 | 1.167 | 0.018* |
Pain relief | age at RT | 1.062 | 1.012 | 1.114 | 0.014* |
Pain relief | gender | 1.432 | 0.469 | 4.376 | 0.529 |
Pain relief | Typ kappa | 2.572 | 0.685 | 9.654 | 0.162 |
Pain relief | Typ lambda | 0.360 | 0.077 | 1.676 | 0.193 |
Pain relief | IgG | 1.228 | 0.405 | 3.702 | 0.717 |
Pain relief | IgA | 1.91 | 0.253 | 3.312 | 0.893 |
Pain relief | concurrent systemic treatment (yes/no) | 1.285 | 0.241 | 6.863 | 0.769 |
Recalcification | α/β =2 Gy | 1.043 | 0.996 | 1.091 | 0.074 |
Recalcification | α/β =10 Gy | 1.050 | 1.000 | 1.101 | 0.048* |
Recalcification | target volume | 1.049 | 1.000 | 1.100 | 0.050* |
Recalcification | age at RT | 1.023 | 0.983 | 1.064 | 0.272 |
Multivariate analysis | |||||
Pain relief | α/β =10 Gy | 1.087 | 1.007 | 1.172 | 0.032* |
Pain relief | age at RT | 1.066 | 1.008 | 1.127 | 0.025* |
Recalcification | α/β =10 Gy | 1.050 | 1.000 | 1.101 | 0.048* |
CL Confidence Level, *significance.
Univariate Analysis.